Free Trial

Chardan Capital Analyst Recommendations & Stock Picks

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Chardan Capital. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Chardan Capital.

MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
CompanyCurrent PriceRating DateActionBrokerageAnalystRatingPrice TargetImpact on PriceDetailsActions
Adverum Biotechnologies, Inc. stock logo
ADVM
Adverum Biotechnologies
$7.84
+1.0%
7/18/2024Target Raised byChardan Capital-Buy -> Buy$4.00 -> $40.00LowView details for Chardan Capital rating of Adverum Biotechnologies (NASDAQ:ADVM) on 7/18/2024
Arrowhead Pharmaceuticals, Inc. stock logo
ARWR
Arrowhead Pharmaceuticals
$28.78
+0.1%
7/17/2024Reiterated byChardan Capital-Buy -> Buy$60.00 -> $60.00LowView details for Chardan Capital rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 7/17/2024
4D Molecular Therapeutics, Inc. stock logo
FDMT
4D Molecular Therapeutics
$17.94
+5.0%
7/17/2024Reiterated byChardan Capital-Buy -> Buy$38.00 -> $38.00LowView details for Chardan Capital rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 7/17/2024
Lexeo Therapeutics, Inc. stock logo
LXEO
Lexeo Therapeutics
$11.77
+2.0%
7/15/2024Reiterated byChardan Capital-Buy -> Buy$23.00 -> $23.00LowView details for Chardan Capital rating of Lexeo Therapeutics (NASDAQ:LXEO) on 7/15/2024
CARGO Therapeutics, Inc. stock logo
CRGX
CARGO Therapeutics
$17.50
+3.7%
7/8/2024Initiated byChardan CapitalAnalyst G. LivshitsBuy$28.00LowView details for Chardan Capital rating of CARGO Therapeutics (NASDAQ:CRGX) on 7/8/2024
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
$24.87
+3.3%
6/28/2024Reiterated byChardan Capital-Buy -> Buy$62.00 -> $62.00LowView details for Chardan Capital rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 6/28/2024
Silence Therapeutics plc stock logo
SLN
Silence Therapeutics
$21.74
+1.5%
6/28/2024Target Raised byChardan Capital-Buy -> Buy$42.00 -> $55.00LowView details for Chardan Capital rating of Silence Therapeutics (NASDAQ:SLN) on 6/28/2024
EyePoint Pharmaceuticals, Inc. stock logo
EYPT
EyePoint Pharmaceuticals
$9.57
+7.1%
6/28/2024Reiterated byChardan Capital-Buy -> Buy$28.00 -> $28.00LowView details for Chardan Capital rating of EyePoint Pharmaceuticals (NASDAQ:EYPT) on 6/28/2024
Arrowhead Pharmaceuticals, Inc. stock logo
ARWR
Arrowhead Pharmaceuticals
$28.78
+0.1%
6/26/2024Reiterated byChardan Capital-Buy -> Buy$60.00 -> $60.00LowView details for Chardan Capital rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 6/26/2024
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
$2.29
+5.0%
6/18/2024Reiterated byChardan Capital-Buy -> Buy$7.00 -> $7.00LowView details for Chardan Capital rating of Taysha Gene Therapies (NASDAQ:TSHA) on 6/18/2024
Avidity Biosciences, Inc. stock logo
RNA
Avidity Biosciences
$45.96
-0.7%
6/12/2024Target Raised byChardan Capital-Buy -> Buy$33.00 -> $45.00LowView details for Chardan Capital rating of Avidity Biosciences (NASDAQ:RNA) on 6/12/2024
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
$8.08
+1.3%
6/12/2024Reiterated byChardan Capital-Buy -> Buy$20.00 -> $20.00LowView details for Chardan Capital rating of Orchestra BioMed (NASDAQ:OBIO) on 6/12/2024
Oculis Holding AG stock logo
OCS
Oculis
$11.53
-1.3%
6/11/2024Reiterated byChardan Capital-Buy -> Buy$30.00 -> $30.00LowView details for Chardan Capital rating of Oculis (NASDAQ:OCS) on 6/11/2024
Cognition Therapeutics, Inc. stock logo
CGTX
Cognition Therapeutics
$1.79
-4.8%
6/6/2024Initiated byChardan CapitalAnalyst D. GataulinBuy$11.00LowView details for Chardan Capital rating of Cognition Therapeutics (NASDAQ:CGTX) on 6/6/2024
Coya Therapeutics, Inc. stock logo
COYA
Coya Therapeutics
$7.18
-3.6%
6/5/2024Reiterated byChardan Capital-Buy -> Buy$14.00 -> $14.00LowView details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 6/5/2024
Arbutus Biopharma Co. stock logo
ABUS
Arbutus Biopharma
$3.83
+0.5%
6/5/2024Reiterated byChardan Capital-Buy -> Buy$4.00 -> $4.00LowView details for Chardan Capital rating of Arbutus Biopharma (NASDAQ:ABUS) on 6/5/2024
iBio, Inc. stock logo
IBIO
iBio
$2.30
+4.1%
6/3/2024Reiterated byChardan CapitalAnalyst K. NakaeBuy -> Buy$5.00 -> $5.00LowView details for Chardan Capital rating of iBio (NYSE:IBIO) on 6/3/2024
Arrowhead Pharmaceuticals, Inc. stock logo
ARWR
Arrowhead Pharmaceuticals
$28.78
+0.1%
6/3/2024Reiterated byChardan Capital-Buy -> Buy$60.00 -> $60.00LowView details for Chardan Capital rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 6/3/2024
NOVONIX Limited stock logo
NVX
NOVONIX
$1.78
5/30/2024Initiated byChardan CapitalAnalyst B. DobsonBuy$4.00LowView details for Chardan Capital rating of NOVONIX (NASDAQ:NVX) on 5/30/2024
iBio, Inc. stock logo
IBIO
iBio
$2.30
+4.1%
5/28/2024Initiated byChardan CapitalAnalyst K. NakaeBuy$5.00LowView details for Chardan Capital rating of iBio (NYSE:IBIO) on 5/28/2024
Freightos Limited stock logo
CRGO
Freightos
$1.74
-1.1%
5/23/2024Target Lowered byChardan Capital-Buy -> Buy$8.00 -> $6.00LowView details for Chardan Capital rating of Freightos (NASDAQ:CRGO) on 5/23/2024
SAB Biotherapeutics, Inc. stock logo
SABS
SAB Biotherapeutics
$2.70
-5.3%
5/21/2024Reiterated byChardan Capital-Buy -> Buy$25.00 -> $25.00LowView details for Chardan Capital rating of SAB Biotherapeutics (NASDAQ:SABS) on 5/21/2024
Dyne Therapeutics, Inc. stock logo
DYN
Dyne Therapeutics
$44.03
+1.9%
5/21/2024Target Raised byChardan Capital-Buy -> Buy$31.00 -> $42.00LowView details for Chardan Capital rating of Dyne Therapeutics (NASDAQ:DYN) on 5/21/2024
BM Technologies, Inc. stock logo
BMTX
BM Technologies
$3.01
-2.3%
5/20/2024Reiterated byChardan Capital-Buy -> Buy$8.00 -> $8.00LowView details for Chardan Capital rating of BM Technologies (NYSE:BMTX) on 5/20/2024
Silence Therapeutics plc stock logo
SLN
Silence Therapeutics
$21.74
+1.5%
5/17/2024Reiterated byChardan Capital-Buy -> Buy$42.00 -> $42.00LowView details for Chardan Capital rating of Silence Therapeutics (NASDAQ:SLN) on 5/17/2024
Allurion Technologies Inc. stock logo
ALUR
Allurion Technologies
$0.87
5/15/2024Reiterated byChardan Capital-Buy -> Buy$5.00 -> $5.00LowView details for Chardan Capital rating of Allurion Technologies (NYSE:ALUR) on 5/15/2024
Ocugen, Inc. stock logo
OCGN
Ocugen
$1.70
+3.7%
5/15/2024Reiterated byChardan Capital-Buy -> Buy$5.00 -> $5.00LowView details for Chardan Capital rating of Ocugen (NASDAQ:OCGN) on 5/15/2024
CleanSpark, Inc. stock logo
CLSK
CleanSpark
$17.45
-3.8%
5/13/2024Reiterated byChardan Capital-Buy -> Buy$26.00 -> $26.00LowView details for Chardan Capital rating of CleanSpark (NASDAQ:CLSK) on 5/13/2024
Avidity Biosciences, Inc. stock logo
RNA
Avidity Biosciences
$45.96
-0.7%
5/10/2024Reiterated byChardan Capital-Buy -> Buy$33.00 -> $33.00LowView details for Chardan Capital rating of Avidity Biosciences (NASDAQ:RNA) on 5/10/2024
ProQR Therapeutics stock logo
PRQR
ProQR Therapeutics
$1.89
+4.4%
5/10/2024Reiterated byChardan CapitalAnalyst K. NakaeBuy -> Buy$2.50 -> $2.50LowView details for Chardan Capital rating of ProQR Therapeutics (NASDAQ:PRQR) on 5/10/2024
Arrowhead Pharmaceuticals, Inc. stock logo
ARWR
Arrowhead Pharmaceuticals
$28.78
+0.1%
5/10/2024Reiterated byChardan Capital-Buy -> Buy$60.00 -> $60.00LowView details for Chardan Capital rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 5/10/2024
Wag! Group Co. stock logo
PET
Wag! Group
$1.31
-0.8%
5/10/2024Reiterated byChardan Capital-Buy -> Buy$8.00 -> $8.00LowView details for Chardan Capital rating of Wag! Group (NASDAQ:PET) on 5/10/2024
Coya Therapeutics, Inc. stock logo
COYA
Coya Therapeutics
$7.18
-3.6%
5/9/2024Reiterated byChardan Capital-Buy -> Buy$14.00 -> $14.00LowView details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 5/9/2024
Valens Semiconductor Ltd. stock logo
VLN
Valens Semiconductor
$2.50
-0.8%
5/9/2024Reiterated byChardan Capital-Buy -> Buy$4.00 -> $4.00LowView details for Chardan Capital rating of Valens Semiconductor (NYSE:VLN) on 5/9/2024
Solid Power, Inc. stock logo
SLDP
Solid Power
$2.12
+1.9%
5/8/2024Reiterated byChardan Capital-Buy -> Buy$5.00 -> $5.00LowView details for Chardan Capital rating of Solid Power (NASDAQ:SLDP) on 5/8/2024
Seres Therapeutics, Inc. stock logo
MCRB
Seres Therapeutics
$1.13
-8.1%
5/8/2024Target Lowered byChardan Capital-Buy -> Buy$8.00 -> $6.00LowView details for Chardan Capital rating of Seres Therapeutics (NASDAQ:MCRB) on 5/8/2024
PLBY Group, Inc. stock logo
PLBY
PLBY Group
$0.86
-4.4%
5/8/2024Reiterated byChardan Capital-Buy -> Buy$4.00 -> $4.00LowView details for Chardan Capital rating of PLBY Group (NASDAQ:PLBY) on 5/8/2024
Marathon Digital Holdings, Inc. stock logo
MARA
Marathon Digital
$21.65
-9.6%
5/8/2024Target Lowered byChardan Capital-Neutral -> Neutral$30.00 -> $21.00LowView details for Chardan Capital rating of Marathon Digital (NASDAQ:MARA) on 5/8/2024
CleanSpark, Inc. stock logo
CLSK
CleanSpark
$17.45
-3.8%
5/7/2024Reiterated byChardan Capital-Buy -> Buy$26.00 -> $26.00LowView details for Chardan Capital rating of CleanSpark (NASDAQ:CLSK) on 5/7/2024
Omega Therapeutics, Inc. stock logo
OMGA
Omega Therapeutics
$1.93
+4.3%
5/7/2024Reiterated byChardan Capital-Buy -> Buy$7.00 -> $7.00LowView details for Chardan Capital rating of Omega Therapeutics (NASDAQ:OMGA) on 5/7/2024
Jeff Bezos Just Humiliated Elon Musk (Ad)

The Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet… but in the next 6 months that’s all they’ll talk about.

Go here now for this breaking story.
EyePoint Pharmaceuticals, Inc. stock logo
EYPT
EyePoint Pharmaceuticals
$9.57
+7.1%
5/7/2024Target Lowered byChardan Capital-Buy -> Buy$39.00 -> $28.00LowView details for Chardan Capital rating of EyePoint Pharmaceuticals (NASDAQ:EYPT) on 5/7/2024
Dyne Therapeutics, Inc. stock logo
DYN
Dyne Therapeutics
$44.03
+1.9%
5/6/2024Reiterated byChardan Capital-Buy -> Buy$31.00 -> $31.00LowView details for Chardan Capital rating of Dyne Therapeutics (NASDAQ:DYN) on 5/6/2024
Arbutus Biopharma Co. stock logo
ABUS
Arbutus Biopharma
$3.83
+0.5%
5/3/2024Reiterated byChardan Capital-Buy -> Buy$4.00 -> $4.00LowView details for Chardan Capital rating of Arbutus Biopharma (NASDAQ:ABUS) on 5/3/2024
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
$234.29
-0.6%
5/3/2024Reiterated byChardan Capital-Buy -> Buy$225.00 -> $225.00LowView details for Chardan Capital rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 5/3/2024
Coya Therapeutics, Inc. stock logo
COYA
Coya Therapeutics
$7.18
-3.6%
4/29/2024Reiterated byChardan Capital-Buy -> Buy$14.00 -> $14.00LowView details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 4/29/2024
BM Technologies, Inc. stock logo
BMTX
BM Technologies
$3.01
-2.3%
4/22/2024Reiterated byChardan Capital-Buy -> Buy$8.00 -> $8.00LowView details for Chardan Capital rating of BM Technologies (NYSE:BMTX) on 4/22/2024
Ocugen, Inc. stock logo
OCGN
Ocugen
$1.70
+3.7%
4/22/2024Target Raised byChardan Capital-Buy -> Buy$4.00 -> $5.00LowView details for Chardan Capital rating of Ocugen (NASDAQ:OCGN) on 4/22/2024
Prime Medicine, Inc. stock logo
PRME
Prime Medicine
$5.79
+6.8%
4/22/2024Initiated byChardan Capital-Buy$17.00LowView details for Chardan Capital rating of Prime Medicine (NYSE:PRME) on 4/22/2024
Li-Cycle Holdings Corp. stock logo
LICY
Li-Cycle
$3.78
-0.8%
4/19/2024Reiterated byChardan Capital-Neutral -> Neutral$6.00LowView details for Chardan Capital rating of Li-Cycle (NYSE:LICY) on 4/19/2024
Dragonfly Energy Holdings Corp. stock logo
DFLI
Dragonfly Energy
$0.88
+6.0%
4/16/2024Reiterated byChardan Capital-Buy -> Buy$3.00LowView details for Chardan Capital rating of Dragonfly Energy (NASDAQ:DFLI) on 4/16/2024
SAB Biotherapeutics, Inc. stock logo
SABS
SAB Biotherapeutics
$2.70
-5.3%
4/16/2024Reiterated byChardan Capital-Buy -> Buy$25.00LowView details for Chardan Capital rating of SAB Biotherapeutics (NASDAQ:SABS) on 4/16/2024
Energy Vault Holdings, Inc. stock logo
NRGV
Energy Vault
$1.13
+0.9%
4/8/2024Reiterated byChardan Capital-Buy -> Sell$7.00 -> $0.75LowView details for Chardan Capital rating of Energy Vault (NYSE:NRGV) on 4/8/2024
Achilles Therapeutics plc stock logo
ACHL
Achilles Therapeutics
$0.83
+1.2%
4/5/2024Target Lowered byChardan Capital-Buy -> Buy$11.00 -> $6.00LowView details for Chardan Capital rating of Achilles Therapeutics (NASDAQ:ACHL) on 4/5/2024
BM Technologies, Inc. stock logo
BMTX
BM Technologies
$3.01
-2.3%
4/4/2024Reiterated byChardan Capital-Buy -> Buy$8.00LowView details for Chardan Capital rating of BM Technologies (NYSE:BMTX) on 4/4/2024
Allurion Technologies Inc. stock logo
ALUR
Allurion Technologies
$0.87
4/4/2024Initiated byChardan Capital-Buy$5.00LowView details for Chardan Capital rating of Allurion Technologies (NYSE:ALUR) on 4/4/2024
Ouster, Inc. stock logo
OUST
Ouster
$14.71
+3.8%
4/3/2024Reiterated byChardan Capital-Buy -> Neutral$10.00LowView details for Chardan Capital rating of Ouster (NYSE:OUST) on 4/3/2024
SAB Biotherapeutics, Inc. stock logo
SABS
SAB Biotherapeutics
$2.70
-5.3%
4/2/2024Target Raised byChardan Capital-Buy -> Buy$3.00 -> $25.00LowView details for Chardan Capital rating of SAB Biotherapeutics (NASDAQ:SABS) on 4/2/2024
Femasys Inc. stock logo
FEMY
Femasys
$1.11
-0.9%
4/1/2024Reiterated byChardan Capital-Buy -> Buy$12.00LowView details for Chardan Capital rating of Femasys (NASDAQ:FEMY) on 4/1/2024
Omega Therapeutics, Inc. stock logo
OMGA
Omega Therapeutics
$1.93
+4.3%
4/1/2024Target Lowered byChardan Capital-Buy -> Buy$12.00 -> $7.00LowView details for Chardan Capital rating of Omega Therapeutics (NASDAQ:OMGA) on 4/1/2024
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
$8.08
+1.3%
3/28/2024Reiterated byChardan Capital-Buy -> Buy$20.00LowView details for Chardan Capital rating of Orchestra BioMed (NASDAQ:OBIO) on 3/28/2024
Metagenomi, Inc. stock logo
MGX
Metagenomi
$4.65
+4.0%
3/28/2024Reiterated byChardan Capital-Buy -> Buy$21.00LowView details for Chardan Capital rating of Metagenomi (NASDAQ:MGX) on 3/28/2024
Gain Therapeutics, Inc. stock logo
GANX
Gain Therapeutics
$1.12
-3.4%
3/27/2024Reiterated byChardan Capital-Buy -> Buy$6.00LowView details for Chardan Capital rating of Gain Therapeutics (NASDAQ:GANX) on 3/27/2024
PLBY Group, Inc. stock logo
PLBY
PLBY Group
$0.86
-4.4%
3/26/2024Reiterated byChardan Capital-Buy -> Buy$4.00LowView details for Chardan Capital rating of PLBY Group (NASDAQ:PLBY) on 3/26/2024
Tenaya Therapeutics, Inc. stock logo
TNYA
Tenaya Therapeutics
$3.76
+2.5%
3/21/2024Reiterated byChardan Capital-Buy -> Buy$20.00LowView details for Chardan Capital rating of Tenaya Therapeutics (NASDAQ:TNYA) on 3/21/2024
Femasys Inc. stock logo
FEMY
Femasys
$1.11
-0.9%
3/21/2024Reiterated byChardan Capital-Buy -> Buy$12.00LowView details for Chardan Capital rating of Femasys (NASDAQ:FEMY) on 3/21/2024
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
$2.29
+5.0%
3/21/2024Target Raised byChardan Capital-Buy -> Buy$5.00 -> $7.00LowView details for Chardan Capital rating of Taysha Gene Therapies (NASDAQ:TSHA) on 3/21/2024
Coya Therapeutics, Inc. stock logo
COYA
Coya Therapeutics
$7.18
-3.6%
3/20/2024Target Raised byChardan Capital-Buy -> Buy$11.00 -> $14.00LowView details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 3/20/2024
Oculis Holding AG stock logo
OCS
Oculis
$11.53
-1.3%
3/19/2024Reiterated byChardan CapitalAnalyst D. GataulinBuy -> Buy$30.00LowView details for Chardan Capital rating of Oculis (NASDAQ:OCS) on 3/19/2024
Adverum Biotechnologies, Inc. stock logo
ADVM
Adverum Biotechnologies
$7.84
+1.0%
3/19/2024Reiterated byChardan Capital-Buy -> Buy$4.00LowView details for Chardan Capital rating of Adverum Biotechnologies (NASDAQ:ADVM) on 3/19/2024
ProQR Therapeutics stock logo
PRQR
ProQR Therapeutics
$1.89
+4.4%
3/14/2024Target Raised byChardan CapitalAnalyst K. NakaeBuy -> Buy$2.00 -> $2.50LowView details for Chardan Capital rating of ProQR Therapeutics (NASDAQ:PRQR) on 3/14/2024
Silence Therapeutics plc stock logo
SLN
Silence Therapeutics
$21.74
+1.5%
3/14/2024Target Raised byChardan Capital-Buy -> Buy$26.00 -> $42.00LowView details for Chardan Capital rating of Silence Therapeutics (NASDAQ:SLN) on 3/14/2024
Immuneering Co. stock logo
IMRX
Immuneering
$1.19
-0.8%
3/15/2024Target Lowered byChardan Capital-Buy -> Buy$21.00 -> $16.00N/AView details for Chardan Capital rating of Immuneering (NASDAQ:IMRX) on 3/15/2024
ESS Tech, Inc. stock logo
GWH
ESS Tech
$0.81
+2.5%
3/15/2024Target Lowered byChardan Capital-Neutral -> Neutral$1.90 -> $0.80N/AView details for Chardan Capital rating of ESS Tech (NYSE:GWH) on 3/15/2024
Energy Vault Holdings, Inc. stock logo
NRGV
Energy Vault
$1.13
+0.9%
3/18/2024Reiterated byChardan Capital-Buy -> Buy$7.00LowView details for Chardan Capital rating of Energy Vault (NYSE:NRGV) on 3/18/2024
Dyne Therapeutics, Inc. stock logo
DYN
Dyne Therapeutics
$44.03
+1.9%
3/8/2024Target Raised byChardan Capital-Buy$20.00 -> $31.00LowView details for Chardan Capital rating of Dyne Therapeutics (NASDAQ:DYN) on 3/8/2024
REGENXBIO Inc. stock logo
RGNX
REGENXBIO
$13.50
+5.7%
3/7/2024Reiterated byChardan Capital-Buy -> Buy$52.00LowView details for Chardan Capital rating of REGENXBIO (NASDAQ:RGNX) on 3/7/2024
Seres Therapeutics, Inc. stock logo
MCRB
Seres Therapeutics
$1.13
-8.1%
3/6/2024Target Lowered byChardan Capital-Buy -> Buy$10.00 -> $8.00LowView details for Chardan Capital rating of Seres Therapeutics (NASDAQ:MCRB) on 3/6/2024
Metagenomi, Inc. stock logo
MGX
Metagenomi
$4.65
+4.0%
3/5/2024Initiated byChardan Capital-Buy$21.00LowView details for Chardan Capital rating of Metagenomi (NASDAQ:MGX) on 3/5/2024
Marathon Digital Holdings, Inc. stock logo
MARA
Marathon Digital
$21.65
-9.6%
3/4/2024Target Raised byChardan Capital-Neutral -> Neutral$26.00 -> $30.00LowView details for Chardan Capital rating of Marathon Digital (NASDAQ:MARA) on 3/4/2024
CleanSpark, Inc. stock logo
CLSK
CleanSpark
$17.45
-3.8%
3/4/2024Target Raised byChardan Capital-Buy -> Buy$13.00 -> $26.00LowView details for Chardan Capital rating of CleanSpark (NASDAQ:CLSK) on 3/4/2024
Arbutus Biopharma Co. stock logo
ABUS
Arbutus Biopharma
$3.83
+0.5%
3/1/2024Reiterated byChardan Capital-Buy -> Buy$4.00LowView details for Chardan Capital rating of Arbutus Biopharma (NASDAQ:ABUS) on 3/1/2024
Avidity Biosciences, Inc. stock logo
RNA
Avidity Biosciences
$45.96
-0.7%
2/29/2024Reiterated byChardan Capital-Buy -> Buy$23.00LowView details for Chardan Capital rating of Avidity Biosciences (NASDAQ:RNA) on 2/29/2024
Solid Power, Inc. stock logo
SLDP
Solid Power
$2.12
+1.9%
2/28/2024Reiterated byChardan Capital-Buy -> Buy$5.00LowView details for Chardan Capital rating of Solid Power (NASDAQ:SLDP) on 2/28/2024
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
$57.19
+1.7%
2/22/2024Target Raised byChardan Capital-Buy -> Buy$110.00 -> $112.00LowView details for Chardan Capital rating of CRISPR Therapeutics (NASDAQ:CRSP) on 2/22/2024
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
$8.69
+4.3%
2/20/2024Target Raised byChardan Capital-Buy -> Buy$29.00 -> $34.00LowView details for Chardan Capital rating of Iovance Biotherapeutics (NASDAQ:IOVA) on 2/20/2024
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
$234.29
-0.6%
2/16/2024Target Lowered byChardan Capital-Buy -> Buy$250.00 -> $225.00LowView details for Chardan Capital rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 2/16/2024
Outlook Therapeutics, Inc. stock logo
OTLK
Outlook Therapeutics
$8.52
+4.8%
2/15/2024Upgraded byChardan CapitalAnalyst D. GataulinNeutral -> Buy$60.00LowView details for Chardan Capital rating of Outlook Therapeutics (NASDAQ:OTLK) on 2/15/2024
Synlogic, Inc. stock logo
SYBX
Synlogic
$1.64
2/9/2024Downgraded byChardan CapitalAnalyst K. NakaeBuy -> NeutralLowView details for Chardan Capital rating of Synlogic (NASDAQ:SYBX) on 2/9/2024
Oculis Holding AG stock logo
OCS
Oculis
$11.53
-1.3%
12/5/2023Initiated byChardan CapitalAnalyst D. GataulinBuy$30.00LowView details for Chardan Capital rating of Oculis (NASDAQ:OCS) on 12/5/2023
Lexeo Therapeutics, Inc. stock logo
LXEO
Lexeo Therapeutics
$11.77
+2.0%
11/28/2023Initiated byChardan CapitalAnalyst G. LivshitsBuy$23.00LowView details for Chardan Capital rating of Lexeo Therapeutics (NASDAQ:LXEO) on 11/28/2023
Jeff Bezos Just Humiliated Elon Musk (Ad)

The Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet… but in the next 6 months that’s all they’ll talk about.

Go here now for this breaking story.
Li-Cycle Holdings Corp. stock logo
LICY
Li-Cycle
$3.78
-0.8%
11/16/2023Downgraded byChardan Capital-Buy -> NeutralLowView details for Chardan Capital rating of Li-Cycle (NYSE:LICY) on 11/16/2023
ProQR Therapeutics stock logo
PRQR
ProQR Therapeutics
$1.89
+4.4%
11/8/2023Upgraded byChardan CapitalAnalyst K. NakaeNeutral -> Buy$2.00LowView details for Chardan Capital rating of ProQR Therapeutics (NASDAQ:PRQR) on 11/8/2023
Wallbox stock logo
WBX
Wallbox
$1.41
-5.4%
10/19/2023Downgraded byChardan Capital-Buy -> Neutral$2.25LowView details for Chardan Capital rating of Wallbox (NYSE:WBX) on 10/19/2023
Voyager Therapeutics, Inc. stock logo
VYGR
Voyager Therapeutics
$8.86
+1.0%
9/18/2023Reiterated byChardan CapitalAnalyst G. LivshitsNeutralLowView details for Chardan Capital rating of Voyager Therapeutics (NASDAQ:VYGR) on 9/18/2023
Outlook Therapeutics, Inc. stock logo
OTLK
Outlook Therapeutics
$8.52
+4.8%
8/31/2023Downgraded byChardan CapitalAnalyst D. GataulinBuy -> NeutralLowView details for Chardan Capital rating of Outlook Therapeutics (NASDAQ:OTLK) on 8/31/2023
Zura Bio Limited stock logo
ZURA
Zura Bio
$3.84
+7.6%
8/17/2023Reiterated byChardan CapitalAnalyst D. GataulinBuyLowView details for Chardan Capital rating of Zura Bio (NASDAQ:ZURA) on 8/17/2023
uniQure stock logo
QURE
uniQure
$8.04
+5.4%
8/17/2023Reiterated byChardan CapitalAnalyst Y. LivshitsBuyLowView details for Chardan Capital rating of uniQure (NASDAQ:QURE) on 8/17/2023
PLBY Group, Inc. stock logo
PLBY
PLBY Group
$0.86
-4.4%
8/17/2023Target Lowered byChardan Capital-Buy -> Buy$5.00 -> $4.00LowView details for Chardan Capital rating of PLBY Group (NASDAQ:PLBY) on 8/17/2023
Silence Therapeutics plc stock logo
SLN
Silence Therapeutics
$21.74
+1.5%
8/17/2023Reiterated byChardan Capital-Buy -> Buy$26.00LowView details for Chardan Capital rating of Silence Therapeutics (NASDAQ:SLN) on 8/17/2023
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
$8.69
+4.3%
8/16/2023Reiterated byChardan Capital-Buy -> Buy$29.00LowView details for Chardan Capital rating of Iovance Biotherapeutics (NASDAQ:IOVA) on 8/16/2023
Li-Cycle Holdings Corp. stock logo
LICY
Li-Cycle
$3.78
-0.8%
8/16/2023Target Lowered byChardan Capital-Buy -> Buy$64.00 -> $56.00LowView details for Chardan Capital rating of Li-Cycle (NYSE:LICY) on 8/16/2023
Valens Semiconductor Ltd. stock logo
VLN
Valens Semiconductor
$2.50
-0.8%
8/15/2023Target Lowered byChardan Capital-Buy -> Buy$9.00 -> $5.00LowView details for Chardan Capital rating of Valens Semiconductor (NYSE:VLN) on 8/15/2023
Senti Biosciences, Inc. stock logo
SNTI
Senti Biosciences
$2.35
-2.5%
8/15/2023Reiterated byChardan Capital-Buy -> Buy$60.00LowView details for Chardan Capital rating of Senti Biosciences (NASDAQ:SNTI) on 8/15/2023
Outlook Therapeutics, Inc. stock logo
OTLK
Outlook Therapeutics
$8.52
+4.8%
8/15/2023Reiterated byChardan Capital-Buy -> Buy$200.00LowView details for Chardan Capital rating of Outlook Therapeutics (NASDAQ:OTLK) on 8/15/2023
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
$2.29
+5.0%
8/15/2023Reiterated byChardan Capital-Buy -> Buy$5.00LowView details for Chardan Capital rating of Taysha Gene Therapies (NASDAQ:TSHA) on 8/15/2023
Tenaya Therapeutics, Inc. stock logo
TNYA
Tenaya Therapeutics
$3.76
+2.5%
8/14/2023Reiterated byChardan Capital-Buy -> Buy$23.00LowView details for Chardan Capital rating of Tenaya Therapeutics (NASDAQ:TNYA) on 8/14/2023
Gain Therapeutics, Inc. stock logo
GANX
Gain Therapeutics
$1.12
-3.4%
8/14/2023Reiterated byChardan Capital-Buy -> Buy$6.00LowView details for Chardan Capital rating of Gain Therapeutics (NASDAQ:GANX) on 8/14/2023
Synlogic, Inc. stock logo
SYBX
Synlogic
$1.64
8/11/2023Reiterated byChardan Capital-Buy -> Buy$90.00LowView details for Chardan Capital rating of Synlogic (NASDAQ:SYBX) on 8/11/2023
CleanSpark, Inc. stock logo
CLSK
CleanSpark
$17.45
-3.8%
8/11/2023Target Raised byChardan Capital-Buy -> Buy$10.00 -> $11.00LowView details for Chardan Capital rating of CleanSpark (NASDAQ:CLSK) on 8/11/2023
MeiraGTx Holdings plc stock logo
MGTX
MeiraGTx
$4.77
+2.6%
8/11/2023Reiterated byChardan Capital-Buy -> Buy$41.00LowView details for Chardan Capital rating of MeiraGTx (NASDAQ:MGTX) on 8/11/2023
4D Molecular Therapeutics, Inc. stock logo
FDMT
4D Molecular Therapeutics
$17.94
+5.0%
8/11/2023Reiterated byChardan Capital-Buy -> Buy$31.00LowView details for Chardan Capital rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 8/11/2023
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
$24.87
+3.3%
8/11/2023Reiterated byChardan Capital-Buy -> Buy$61.00LowView details for Chardan Capital rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 8/11/2023
Femasys Inc. stock logo
FEMY
Femasys
$1.11
-0.9%
8/11/2023Reiterated byChardan Capital-Buy -> Buy$10.00LowView details for Chardan Capital rating of Femasys (NASDAQ:FEMY) on 8/11/2023
Adverum Biotechnologies, Inc. stock logo
ADVM
Adverum Biotechnologies
$7.84
+1.0%
8/11/2023Upgraded byChardan CapitalAnalyst D. GataulinNeutral -> Buy$20.00 -> $40.00LowView details for Chardan Capital rating of Adverum Biotechnologies (NASDAQ:ADVM) on 8/11/2023
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
$8.08
+1.3%
8/9/2023Reiterated byChardan CapitalAnalyst K. NakaeBuy -> Buy$20.00LowView details for Chardan Capital rating of Orchestra BioMed (NASDAQ:OBIO) on 8/9/2023
Coya Therapeutics, Inc. stock logo
COYA
Coya Therapeutics
$7.18
-3.6%
8/9/2023Reiterated byChardan Capital-Buy -> Buy$11.00LowView details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 8/9/2023
Energy Vault Holdings, Inc. stock logo
NRGV
Energy Vault
$1.13
+0.9%
8/9/2023Reiterated byChardan Capital-Buy -> Buy$7.00LowView details for Chardan Capital rating of Energy Vault (NYSE:NRGV) on 8/9/2023
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
$8.69
+4.3%
8/9/2023Reiterated byChardan Capital-Buy -> Buy$29.00LowView details for Chardan Capital rating of Iovance Biotherapeutics (NASDAQ:IOVA) on 8/9/2023
Wag! Group Co. stock logo
PET
Wag! Group
$1.31
-0.8%
8/10/2023Reiterated byChardan Capital-Buy -> Buy$8.00N/AView details for Chardan Capital rating of Wag! Group (NASDAQ:PET) on 8/10/2023
Solid Power, Inc. stock logo
SLDP
Solid Power
$2.12
+1.9%
8/10/2023Reiterated byChardan Capital-Buy -> Buy$5.00N/AView details for Chardan Capital rating of Solid Power (NASDAQ:SLDP) on 8/10/2023
Century Therapeutics, Inc. stock logo
IPSC
Century Therapeutics
$2.48
+1.6%
8/9/2023Target Lowered byChardan Capital-Buy -> Buy$19.00 -> $17.00LowView details for Chardan Capital rating of Century Therapeutics (NASDAQ:IPSC) on 8/9/2023
Avidity Biosciences, Inc. stock logo
RNA
Avidity Biosciences
$45.96
-0.7%
8/9/2023Target Lowered byChardan Capital-Buy -> Buy$27.00 -> $23.00LowView details for Chardan Capital rating of Avidity Biosciences (NASDAQ:RNA) on 8/9/2023
Arrowhead Pharmaceuticals, Inc. stock logo
ARWR
Arrowhead Pharmaceuticals
$28.78
+0.1%
8/8/2023Reiterated byChardan Capital-Buy -> Buy$60.00LowView details for Chardan Capital rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 8/8/2023
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
$234.29
-0.6%
8/8/2023Reiterated byChardan Capital-Buy -> Buy$250.00LowView details for Chardan Capital rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 8/8/2023
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
$57.19
+1.7%
8/7/2023Target Lowered byChardan Capital-Buy -> Buy$123.00 -> $110.00LowView details for Chardan Capital rating of CRISPR Therapeutics (NASDAQ:CRSP) on 8/7/2023
Krystal Biotech, Inc. stock logo
KRYS
Krystal Biotech
$207.19
+0.2%
8/7/2023Target Raised byChardan Capital-Buy -> Buy$148.00 -> $153.00LowView details for Chardan Capital rating of Krystal Biotech (NASDAQ:KRYS) on 8/7/2023
Passage Bio, Inc. stock logo
PASG
Passage Bio
$0.83
-4.6%
8/7/2023Target Lowered byChardan Capital-Buy -> Buy$11.00 -> $9.00LowView details for Chardan Capital rating of Passage Bio (NASDAQ:PASG) on 8/7/2023
Marathon Digital Holdings, Inc. stock logo
MARA
Marathon Digital
$21.65
-9.6%
8/7/2023Downgraded byChardan Capital-Buy -> Neutral$15.00LowView details for Chardan Capital rating of Marathon Digital (NASDAQ:MARA) on 8/7/2023
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
$26.46
+4.5%
8/7/2023Reiterated byChardan Capital-Buy -> Buy$107.00LowView details for Chardan Capital rating of Intellia Therapeutics (NASDAQ:NTLA) on 8/7/2023
Achilles Therapeutics plc stock logo
ACHL
Achilles Therapeutics
$0.83
+1.2%
8/7/2023Reiterated byChardan Capital-Buy -> Buy$11.00LowView details for Chardan Capital rating of Achilles Therapeutics (NASDAQ:ACHL) on 8/7/2023
Immuneering Co. stock logo
IMRX
Immuneering
$1.19
-0.8%
8/7/2023Reiterated byChardan Capital-Buy -> Buy$22.00LowView details for Chardan Capital rating of Immuneering (NASDAQ:IMRX) on 8/7/2023
Arbutus Biopharma Co. stock logo
ABUS
Arbutus Biopharma
$3.83
+0.5%
8/4/2023Reiterated byChardan Capital-Buy -> Buy$6.00LowView details for Chardan Capital rating of Arbutus Biopharma (NASDAQ:ABUS) on 8/4/2023
Dyne Therapeutics, Inc. stock logo
DYN
Dyne Therapeutics
$44.03
+1.9%
8/4/2023Reiterated byChardan Capital-Buy -> Buy$20.00LowView details for Chardan Capital rating of Dyne Therapeutics (NASDAQ:DYN) on 8/4/2023
Omega Therapeutics, Inc. stock logo
OMGA
Omega Therapeutics
$1.93
+4.3%
8/4/2023Reiterated byChardan Capital-Buy -> Buy$12.00LowView details for Chardan Capital rating of Omega Therapeutics (NASDAQ:OMGA) on 8/4/2023
ProQR Therapeutics stock logo
PRQR
ProQR Therapeutics
$1.89
+4.4%
8/4/2023Reiterated byChardan Capital-Neutral -> Neutral$2.00LowView details for Chardan Capital rating of ProQR Therapeutics (NASDAQ:PRQR) on 8/4/2023
Mesoblast Limited stock logo
MESO
Mesoblast
$8.27
+9.5%
8/4/2023Target Lowered byChardan Capital-Sell -> Sell$4.00 -> $3.00LowView details for Chardan Capital rating of Mesoblast (NASDAQ:MESO) on 8/4/2023
REGENXBIO Inc. stock logo
RGNX
REGENXBIO
$13.50
+5.7%
8/3/2023Reiterated byChardan Capital-Buy$55.00LowView details for Chardan Capital rating of REGENXBIO (NASDAQ:RGNX) on 8/3/2023
EyePoint Pharmaceuticals, Inc. stock logo
EYPT
EyePoint Pharmaceuticals
$9.57
+7.1%
8/3/2023Reiterated byChardan Capital-Buy -> Buy$22.00LowView details for Chardan Capital rating of EyePoint Pharmaceuticals (NASDAQ:EYPT) on 8/3/2023
Editas Medicine, Inc. stock logo
EDIT
Editas Medicine
$5.61
+7.7%
8/2/2023Target Lowered byChardan Capital-Buy -> Buy$22.00 -> $19.00LowView details for Chardan Capital rating of Editas Medicine (NASDAQ:EDIT) on 8/2/2023
Energy Vault Holdings, Inc. stock logo
NRGV
Energy Vault
$1.13
+0.9%
8/2/2023Reiterated byChardan Capital-Buy -> Buy$7.00LowView details for Chardan Capital rating of Energy Vault (NYSE:NRGV) on 8/2/2023
This AI made her leave her job (Ad)

This AI trading tool is probably unlike anything you've ever seen before… It scans the entire market and finds hot stocks that you probably have never even heard of… …it recommends the best potential strategy to use on the names it finds (with historical data to prove it)

Click Here To Read More About This Game Changing AI Tool
Li-Cycle Holdings Corp. stock logo
LICY
Li-Cycle
$3.78
-0.8%
8/1/2023Reiterated byChardan Capital-Buy -> Buy$64.00LowView details for Chardan Capital rating of Li-Cycle (NYSE:LICY) on 8/1/2023
BM Technologies, Inc. stock logo
BMTX
BM Technologies
$3.01
-2.3%
7/26/2023Target Lowered byChardan Capital-Buy$13.00 -> $8.00LowView details for Chardan Capital rating of BM Technologies (NYSE:BMTX) on 7/26/2023
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
$3.12
+4.3%
7/25/2023Downgraded byChardan CapitalAnalyst D. GataulinBuy -> NeutralLowView details for Chardan Capital rating of Kodiak Sciences (NASDAQ:KOD) on 7/25/2023
CleanSpark, Inc. stock logo
CLSK
CleanSpark
$17.45
-3.8%
7/24/2023Target Raised byChardan Capital-Buy$6.00 -> $10.00LowView details for Chardan Capital rating of CleanSpark (NASDAQ:CLSK) on 7/24/2023
Forte Biosciences, Inc. stock logo
FBRX
Forte Biosciences
$0.57
-5.0%
7/16/2023Reiterated byChardan CapitalAnalyst K. NakaeNeutralLowView details for Chardan Capital rating of Forte Biosciences (NASDAQ:FBRX) on 7/16/2023
Dragonfly Energy Holdings Corp. stock logo
DFLI
Dragonfly Energy
$0.88
+6.0%
7/13/2023Reiterated byChardan Capital-Buy -> Buy$10.00LowView details for Chardan Capital rating of Dragonfly Energy (NASDAQ:DFLI) on 7/13/2023
Ouster, Inc. stock logo
OUST
Ouster
$14.71
+3.8%
7/13/2023Upgraded byChardan Capital-Neutral -> Buy$10.00LowView details for Chardan Capital rating of Ouster (NYSE:OUST) on 7/13/2023
Wallbox stock logo
WBX
Wallbox
$1.41
-5.4%
6/30/2023Target Lowered byChardan Capital-Buy$12.00 -> $11.00LowView details for Chardan Capital rating of Wallbox (NYSE:WBX) on 6/30/2023
Zura Bio Limited stock logo
ZURA
Zura Bio
$3.84
+7.6%
7/10/2023Reiterated byChardan CapitalAnalyst M. BarcusBuyLowView details for Chardan Capital rating of Zura Bio (NASDAQ:ZURA) on 7/10/2023
Xilio Therapeutics, Inc. stock logo
XLO
Xilio Therapeutics
$1.01
+2.1%
7/10/2023Reiterated byChardan CapitalAnalyst M. BarcusBuyLowView details for Chardan Capital rating of Xilio Therapeutics (NASDAQ:XLO) on 7/10/2023
uniQure stock logo
QURE
uniQure
$8.04
+5.4%
7/10/2023Reiterated byChardan CapitalAnalyst M. BarcusBuyLowView details for Chardan Capital rating of uniQure (NASDAQ:QURE) on 7/10/2023
Immunovant, Inc. stock logo
IMVT
Immunovant
$27.99
0.0%
7/10/2023Reiterated byChardan CapitalAnalyst M. BarcusBuyLowView details for Chardan Capital rating of Immunovant (NASDAQ:IMVT) on 7/10/2023
Immunome, Inc. stock logo
IMNM
Immunome
$14.82
+7.7%
7/10/2023Reiterated byChardan CapitalAnalyst M. BarcusBuyLowView details for Chardan Capital rating of Immunome (NASDAQ:IMNM) on 7/10/2023
4D Molecular Therapeutics, Inc. stock logo
FDMT
4D Molecular Therapeutics
$17.94
+5.0%
7/11/2023Target Raised byChardan Capital-$30.00 -> $31.00LowView details for Chardan Capital rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 7/11/2023
4D Molecular Therapeutics, Inc. stock logo
FDMT
4D Molecular Therapeutics
$17.94
+5.0%
7/5/2023Initiated byChardan Capital-Buy$30.00LowView details for Chardan Capital rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 7/5/2023
Zura Bio Limited stock logo
ZURA
Zura Bio
$3.84
+7.6%
6/14/2023Initiated byChardan CapitalAnalyst M. BarcusBuy$14.00LowView details for Chardan Capital rating of Zura Bio (NASDAQ:ZURA) on 6/14/2023
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
$26.46
+4.5%
6/13/2023Target Lowered byChardan Capital-$111.00 -> $107.00LowView details for Chardan Capital rating of Intellia Therapeutics (NASDAQ:NTLA) on 6/13/2023
Coya Therapeutics, Inc. stock logo
COYA
Coya Therapeutics
$7.18
-3.6%
6/7/2023Target Raised byChardan CapitalAnalyst K. Nakae$9.00 -> $11.00LowView details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 6/7/2023
Synlogic, Inc. stock logo
SYBX
Synlogic
$1.64
6/6/2023Target Raised byChardan Capital-$82.50 -> $90.00LowView details for Chardan Capital rating of Synlogic (NASDAQ:SYBX) on 6/6/2023
Mesoblast Limited stock logo
MESO
Mesoblast
$8.27
+9.5%
5/30/2023Target Lowered byChardan Capital-$5.00 -> $4.00LowView details for Chardan Capital rating of Mesoblast (NASDAQ:MESO) on 5/30/2023
Immunovant, Inc. stock logo
IMVT
Immunovant
$27.99
0.0%
5/22/2023Target Raised byChardan Capital-$21.00 -> $32.00LowView details for Chardan Capital rating of Immunovant (NASDAQ:IMVT) on 5/22/2023
Krystal Biotech, Inc. stock logo
KRYS
Krystal Biotech
$207.19
+0.2%
5/22/2023Target Raised byChardan Capital-$133.00 -> $148.00LowView details for Chardan Capital rating of Krystal Biotech (NASDAQ:KRYS) on 5/22/2023
EyePoint Pharmaceuticals, Inc. stock logo
EYPT
EyePoint Pharmaceuticals
$9.57
+7.1%
5/18/2023Target Raised byChardan Capital-$21.00 -> $22.00LowView details for Chardan Capital rating of EyePoint Pharmaceuticals (NASDAQ:EYPT) on 5/18/2023
Forte Biosciences, Inc. stock logo
FBRX
Forte Biosciences
$0.57
-5.0%
5/15/2023Reiterated byChardan CapitalAnalyst K. NakaeNeutralLowView details for Chardan Capital rating of Forte Biosciences (NASDAQ:FBRX) on 5/15/2023
Nauticus Robotics, Inc. stock logo
KITT
Nauticus Robotics
$3.27
+3,533.3%
5/12/2023Downgraded byChardan Capital-Buy -> Neutral$90.00LowView details for Chardan Capital rating of Nauticus Robotics (NASDAQ:KITT) on 5/12/2023
Tenaya Therapeutics, Inc. stock logo
TNYA
Tenaya Therapeutics
$3.76
+2.5%
5/11/2023Target Lowered byChardan Capital-$24.00 -> $23.00LowView details for Chardan Capital rating of Tenaya Therapeutics (NASDAQ:TNYA) on 5/11/2023
Valens Semiconductor Ltd. stock logo
VLN
Valens Semiconductor
$2.50
-0.8%
5/11/2023Target Lowered byChardan Capital-Buy$13.00 -> $12.00LowView details for Chardan Capital rating of Valens Semiconductor (NYSE:VLN) on 5/11/2023
uniQure stock logo
QURE
uniQure
$8.04
+5.4%
5/10/2023Target Lowered byChardan Capital-$60.00 -> $56.00LowView details for Chardan Capital rating of uniQure (NASDAQ:QURE) on 5/10/2023
Ocugen, Inc. stock logo
OCGN
Ocugen
$1.70
+3.7%
5/7/2023Target Raised byChardan CapitalAnalyst D. Gataulin$3.50 -> $4.00LowView details for Chardan Capital rating of Ocugen (NASDAQ:OCGN) on 5/7/2023
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
$24.87
+3.3%
5/5/2023Target Lowered byChardan Capital-$63.00 -> $61.00LowView details for Chardan Capital rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 5/5/2023
REGENXBIO Inc. stock logo
RGNX
REGENXBIO
$13.50
+5.7%
5/4/2023Target Lowered byChardan Capital-$61.00 -> $55.00LowView details for Chardan Capital rating of REGENXBIO (NASDAQ:RGNX) on 5/4/2023
Seres Therapeutics, Inc. stock logo
MCRB
Seres Therapeutics
$1.13
-8.1%
4/28/2023Target Lowered byChardan Capital-$12.00 -> $10.00LowView details for Chardan Capital rating of Seres Therapeutics (NASDAQ:MCRB) on 4/28/2023
Wallbox stock logo
WBX
Wallbox
$1.41
-5.4%
4/18/2023Reiterated byChardan Capital-Buy$12.00LowView details for Chardan Capital rating of Wallbox (NYSE:WBX) on 4/18/2023
Immuneering Co. stock logo
IMRX
Immuneering
$1.19
-0.8%
4/18/2023Target Raised byChardan Capital-Buy$18.00 -> $22.00LowView details for Chardan Capital rating of Immuneering (NASDAQ:IMRX) on 4/18/2023
Ocugen, Inc. stock logo
OCGN
Ocugen
$1.70
+3.7%
4/14/2023Reiterated byChardan CapitalAnalyst D. GataulinBuy$3.50LowView details for Chardan Capital rating of Ocugen (NASDAQ:OCGN) on 4/14/2023
CleanSpark, Inc. stock logo
CLSK
CleanSpark
$17.45
-3.8%
4/17/2023Reiterated byChardan Capital-Buy$5.00LowView details for Chardan Capital rating of CleanSpark (NASDAQ:CLSK) on 4/17/2023
Marathon Digital Holdings, Inc. stock logo
MARA
Marathon Digital
$21.65
-9.6%
4/3/2023Reiterated byChardan Capital-Buy$15.00LowView details for Chardan Capital rating of Marathon Digital (NASDAQ:MARA) on 4/3/2023
Coya Therapeutics, Inc. stock logo
COYA
Coya Therapeutics
$7.18
-3.6%
3/30/2023Reiterated byChardan CapitalAnalyst K. NakaeBuy$9.00LowView details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 3/30/2023
Avidity Biosciences, Inc. stock logo
RNA
Avidity Biosciences
$45.96
-0.7%
3/31/2023Reiterated byChardan Capital-Buy$27.00N/AView details for Chardan Capital rating of Avidity Biosciences (NASDAQ:RNA) on 3/31/2023
Femasys Inc. stock logo
FEMY
Femasys
$1.11
-0.9%
3/30/2023Target Lowered byChardan Capital-Buy$12.00 -> $10.00LowView details for Chardan Capital rating of Femasys (NASDAQ:FEMY) on 3/30/2023
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
$2.29
+5.0%
3/29/2023Target Lowered byChardan Capital-Buy$6.00 -> $5.00LowView details for Chardan Capital rating of Taysha Gene Therapies (NASDAQ:TSHA) on 3/29/2023
Synlogic, Inc. stock logo
SYBX
Synlogic
$1.64
3/29/2023Target Lowered byChardan Capital-Buy$105.00 -> $82.50LowView details for Chardan Capital rating of Synlogic (NASDAQ:SYBX) on 3/29/2023
Marathon Digital Holdings, Inc. stock logo
MARA
Marathon Digital
$21.65
-9.6%
3/28/2023Target Lowered byChardan Capital-Buy$17.00 -> $15.00LowView details for Chardan Capital rating of Marathon Digital (NASDAQ:MARA) on 3/28/2023
BM Technologies, Inc. stock logo
BMTX
BM Technologies
$3.01
-2.3%
3/29/2023Reiterated byChardan Capital-Buy$13.00LowView details for Chardan Capital rating of BM Technologies (NYSE:BMTX) on 3/29/2023
Gain Therapeutics, Inc. stock logo
GANX
Gain Therapeutics
$1.12
-3.4%
3/27/2023Target Raised byChardan Capital-$4.00 -> $5.75LowView details for Chardan Capital rating of Gain Therapeutics (NASDAQ:GANX) on 3/27/2023
Ouster, Inc. stock logo
OUST
Ouster
$14.71
+3.8%
3/24/2023Downgraded byChardan Capital-Buy -> Neutral$10.00LowView details for Chardan Capital rating of Ouster (NYSE:OUST) on 3/24/2023
Senti Biosciences, Inc. stock logo
SNTI
Senti Biosciences
$2.35
-2.5%
3/23/2023Target Lowered byChardan Capital-Buy$80.00 -> $70.00LowView details for Chardan Capital rating of Senti Biosciences (NASDAQ:SNTI) on 3/23/2023
Immatics stock logo
IMTX
Immatics
$12.92
+4.6%
3/23/2023Target Lowered byChardan Capital-Buy$28.00 -> $25.00LowView details for Chardan Capital rating of Immatics (NASDAQ:IMTX) on 3/23/2023
Coya Therapeutics, Inc. stock logo
COYA
Coya Therapeutics
$7.18
-3.6%
3/22/2023Reiterated byChardan CapitalAnalyst K. NakaeBuy$9.00LowView details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 3/22/2023
Anixa Biosciences, Inc. stock logo
ANIX
Anixa Biosciences
$2.89
-7.7%
3/22/2023Reiterated byChardan CapitalAnalyst M. BarcusBuy$8.00 -> $9.00LowView details for Chardan Capital rating of Anixa Biosciences (NASDAQ:ANIX) on 3/22/2023
This AI made her leave her job (Ad)

This AI trading tool is probably unlike anything you've ever seen before… It scans the entire market and finds hot stocks that you probably have never even heard of… …it recommends the best potential strategy to use on the names it finds (with historical data to prove it)

Click Here To Read More About This Game Changing AI Tool
Cabaletta Bio, Inc. stock logo
CABA
Cabaletta Bio
$7.09
-1.4%
3/22/2023Reiterated byChardan Capital-Buy$12.00LowView details for Chardan Capital rating of Cabaletta Bio (NASDAQ:CABA) on 3/22/2023
Century Therapeutics, Inc. stock logo
IPSC
Century Therapeutics
$2.48
+1.6%
3/22/2023Reiterated byChardan CapitalAnalyst G. LivshitsBuy$19.00LowView details for Chardan Capital rating of Century Therapeutics (NASDAQ:IPSC) on 3/22/2023
Immunome, Inc. stock logo
IMNM
Immunome
$14.82
+7.7%
3/16/2023Target Lowered byChardan Capital-Buy$9.00 -> $8.00LowView details for Chardan Capital rating of Immunome (NASDAQ:IMNM) on 3/16/2023
Freightos Limited stock logo
CRGO
Freightos
$1.74
-1.1%
3/16/2023Target Lowered byChardan Capital-Buy$13.00 -> $11.00LowView details for Chardan Capital rating of Freightos (NASDAQ:CRGO) on 3/16/2023
MeiraGTx Holdings plc stock logo
MGTX
MeiraGTx
$4.77
+2.6%
3/16/2023Target Lowered byChardan Capital-Buy$47.00 -> $41.00LowView details for Chardan Capital rating of MeiraGTx (NASDAQ:MGTX) on 3/16/2023
Silence Therapeutics plc stock logo
SLN
Silence Therapeutics
$21.74
+1.5%
3/16/2023Target Lowered byChardan Capital-Buy$29.00 -> $26.00LowView details for Chardan Capital rating of Silence Therapeutics (NASDAQ:SLN) on 3/16/2023
Energy Vault Holdings, Inc. stock logo
NRGV
Energy Vault
$1.13
+0.9%
3/9/2023Target Lowered byChardan Capital-Buy$13.00 -> $7.00LowView details for Chardan Capital rating of Energy Vault (NYSE:NRGV) on 3/9/2023
Tenaya Therapeutics, Inc. stock logo
TNYA
Tenaya Therapeutics
$3.76
+2.5%
3/9/2023Target Lowered byChardan Capital-Buy$28.00 -> $24.00LowView details for Chardan Capital rating of Tenaya Therapeutics (NASDAQ:TNYA) on 3/9/2023
Seres Therapeutics, Inc. stock logo
MCRB
Seres Therapeutics
$1.13
-8.1%
3/8/2023Reiterated byChardan Capital-Buy$12.00LowView details for Chardan Capital rating of Seres Therapeutics (NASDAQ:MCRB) on 3/8/2023
Achilles Therapeutics plc stock logo
ACHL
Achilles Therapeutics
$0.83
+1.2%
3/8/2023Target Lowered byChardan Capital-$17.00 -> $12.00LowView details for Chardan Capital rating of Achilles Therapeutics (NASDAQ:ACHL) on 3/8/2023
Immuneering Co. stock logo
IMRX
Immuneering
$1.19
-0.8%
3/7/2023Reiterated byChardan Capital-Buy$18.00N/AView details for Chardan Capital rating of Immuneering (NASDAQ:IMRX) on 3/7/2023
EyePoint Pharmaceuticals, Inc. stock logo
EYPT
EyePoint Pharmaceuticals
$9.57
+7.1%
3/3/2023Reiterated byChardan Capital-Buy$21.00LowView details for Chardan Capital rating of EyePoint Pharmaceuticals (NASDAQ:EYPT) on 3/3/2023
ESS Tech, Inc. stock logo
GWH
ESS Tech
$0.81
+2.5%
3/3/2023Target Lowered byChardan Capital-Neutral$4.50 -> $1.80LowView details for Chardan Capital rating of ESS Tech (NYSE:GWH) on 3/3/2023
Valens Semiconductor Ltd. stock logo
VLN
Valens Semiconductor
$2.50
-0.8%
3/3/2023Reiterated byChardan Capital-Buy$13.00LowView details for Chardan Capital rating of Valens Semiconductor (NYSE:VLN) on 3/3/2023
Arbutus Biopharma Co. stock logo
ABUS
Arbutus Biopharma
$3.83
+0.5%
3/3/2023Reiterated byChardan Capital-Buy$6.00LowView details for Chardan Capital rating of Arbutus Biopharma (NASDAQ:ABUS) on 3/3/2023
Dyne Therapeutics, Inc. stock logo
DYN
Dyne Therapeutics
$44.03
+1.9%
3/3/2023Target Raised byChardan Capital-Buy$17.00 -> $20.00LowView details for Chardan Capital rating of Dyne Therapeutics (NASDAQ:DYN) on 3/3/2023
REGENXBIO Inc. stock logo
RGNX
REGENXBIO
$13.50
+5.7%
3/2/2023Reiterated byChardan Capital-Buy$61.00LowView details for Chardan Capital rating of REGENXBIO (NASDAQ:RGNX) on 3/2/2023
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
$8.69
+4.3%
3/1/2023Reiterated byChardan CapitalAnalyst Geulah LivshitsBuy$29.00LowView details for Chardan Capital rating of Iovance Biotherapeutics (NASDAQ:IOVA) on 3/1/2023
Mesoblast Limited stock logo
MESO
Mesoblast
$8.27
+9.5%
3/1/2023Reiterated byChardan Capital-Sell$5.00LowView details for Chardan Capital rating of Mesoblast (NASDAQ:MESO) on 3/1/2023
Avidity Biosciences, Inc. stock logo
RNA
Avidity Biosciences
$45.96
-0.7%
3/1/2023Reiterated byChardan Capital-Buy$27.00LowView details for Chardan Capital rating of Avidity Biosciences (NASDAQ:RNA) on 3/1/2023
Ocugen, Inc. stock logo
OCGN
Ocugen
$1.70
+3.7%
3/1/2023Upgraded byChardan CapitalAnalyst D. GataulinNeutral -> Buy$3.50LowView details for Chardan Capital rating of Ocugen (NASDAQ:OCGN) on 3/1/2023
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
$24.87
+3.3%
3/1/2023Target Lowered byChardan Capital-Buy$65.00 -> $63.00LowView details for Chardan Capital rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 3/1/2023
Krystal Biotech, Inc. stock logo
KRYS
Krystal Biotech
$207.19
+0.2%
2/28/2023Reiterated byChardan Capital-Buy$133.00LowView details for Chardan Capital rating of Krystal Biotech (NASDAQ:KRYS) on 2/28/2023
uniQure stock logo
QURE
uniQure
$8.04
+5.4%
2/28/2023Reiterated byChardan Capital-Buy$60.00LowView details for Chardan Capital rating of uniQure (NASDAQ:QURE) on 2/28/2023
Li-Cycle Holdings Corp. stock logo
LICY
Li-Cycle
$3.78
-0.8%
2/28/2023Reiterated byChardan Capital-Buy$80.00LowView details for Chardan Capital rating of Li-Cycle (NYSE:LICY) on 2/28/2023
Freightos Limited stock logo
CRGO
Freightos
$1.74
-1.1%
2/28/2023Reiterated byChardan Capital-BuyLowView details for Chardan Capital rating of Freightos (NASDAQ:CRGO) on 2/28/2023
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
$26.46
+4.5%
2/24/2023Target Lowered byChardan CapitalAnalyst Geulah LivshitsBuy$129.00 -> $111.00LowView details for Chardan Capital rating of Intellia Therapeutics (NASDAQ:NTLA) on 2/24/2023
Wallbox stock logo
WBX
Wallbox
$1.41
-5.4%
2/24/2023Target Lowered byChardan Capital-Buy$13.00 -> $12.00LowView details for Chardan Capital rating of Wallbox (NYSE:WBX) on 2/24/2023
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
$234.29
-0.6%
2/24/2023Reiterated byChardan Capital-Buy$250.00LowView details for Chardan Capital rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 2/24/2023
Editas Medicine, Inc. stock logo
EDIT
Editas Medicine
$5.61
+7.7%
2/23/2023Target Lowered byChardan Capital-Buy$35.00 -> $22.00LowView details for Chardan Capital rating of Editas Medicine (NASDAQ:EDIT) on 2/23/2023
Wag! Group Co. stock logo
PET
Wag! Group
$1.31
-0.8%
2/22/2023Target Raised byChardan Capital-Buy$5.00 -> $8.00LowView details for Chardan Capital rating of Wag! Group (NASDAQ:PET) on 2/22/2023
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
$57.19
+1.7%
2/22/2023Target Lowered byChardan Capital-Buy$153.00 -> $123.00LowView details for Chardan Capital rating of CRISPR Therapeutics (NASDAQ:CRSP) on 2/22/2023
PLBY Group, Inc. stock logo
PLBY
PLBY Group
$0.86
-4.4%
2/13/2023Reiterated byChardan Capital-Buy$5.00LowView details for Chardan Capital rating of PLBY Group (NASDAQ:PLBY) on 2/13/2023
Dragonfly Energy Holdings Corp. stock logo
DFLI
Dragonfly Energy
$0.88
+6.0%
2/10/2023Target Lowered byChardan Capital-Buy$15.00 -> $10.00LowView details for Chardan Capital rating of Dragonfly Energy (NASDAQ:DFLI) on 2/10/2023
Arrowhead Pharmaceuticals, Inc. stock logo
ARWR
Arrowhead Pharmaceuticals
$28.78
+0.1%
2/10/2023Reiterated byChardan Capital-Buy$60.00LowView details for Chardan Capital rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 2/10/2023
BM Technologies, Inc. stock logo
BMTX
BM Technologies
$3.01
-2.3%
2/7/2023Target Lowered byChardan Capital-Buy$21.00 -> $13.00LowView details for Chardan Capital rating of BM Technologies (NYSE:BMTX) on 2/7/2023
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
$8.08
+1.3%
2/7/2023Initiated byChardan CapitalAnalyst K. NakaeBuy$20.00LowView details for Chardan Capital rating of Orchestra BioMed (NASDAQ:OBIO) on 2/7/2023
Immunovant, Inc. stock logo
IMVT
Immunovant
$27.99
0.0%
2/5/2023Target Raised byChardan Capital-Buy$19.00 -> $21.00LowView details for Chardan Capital rating of Immunovant (NASDAQ:IMVT) on 2/5/2023
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
$2.29
+5.0%
2/1/2023Target Lowered byChardan Capital-Buy$16.00 -> $6.00LowView details for Chardan Capital rating of Taysha Gene Therapies (NASDAQ:TSHA) on 2/1/2023
Li-Cycle Holdings Corp. stock logo
LICY
Li-Cycle
$3.78
-0.8%
1/31/2023Target Lowered byChardan Capital-Buy$104.00 -> $80.00LowView details for Chardan Capital rating of Li-Cycle (NYSE:LICY) on 1/31/2023
Senti Biosciences, Inc. stock logo
SNTI
Senti Biosciences
$2.35
-2.5%
1/27/2023Target Lowered byChardan Capital-Buy$120.00 -> $80.00LowView details for Chardan Capital rating of Senti Biosciences (NASDAQ:SNTI) on 1/27/2023
Coya Therapeutics, Inc. stock logo
COYA
Coya Therapeutics
$7.18
-3.6%
1/26/2023Initiated byChardan CapitalAnalyst K. NakaeBuy$9.00N/AView details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 1/26/2023
Moderna, Inc. stock logo
MRNA
Moderna
$121.25
-1.0%
1/18/2023Target Raised byChardan CapitalAnalyst Y. LivshitsNeutral$191.00 -> $208.00LowView details for Chardan Capital rating of Moderna (NASDAQ:MRNA) on 1/18/2023
Arrowhead Pharmaceuticals, Inc. stock logo
ARWR
Arrowhead Pharmaceuticals
$28.78
+0.1%
1/10/2023Target Lowered byChardan Capital-$82.00 -> $60.00LowView details for Chardan Capital rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 1/10/2023
Century Therapeutics, Inc. stock logo
IPSC
Century Therapeutics
$2.48
+1.6%
12/27/2022Initiated byChardan CapitalAnalyst G. LivshitsBuy$19.00LowView details for Chardan Capital rating of Century Therapeutics (NASDAQ:IPSC) on 12/27/2022
Anixa Biosciences, Inc. stock logo
ANIX
Anixa Biosciences
$2.89
-7.7%
12/23/2022Initiated byChardan Capital-Buy$8.00LowView details for Chardan Capital rating of Anixa Biosciences (NASDAQ:ANIX) on 12/23/2022
Xilio Therapeutics, Inc. stock logo
XLO
Xilio Therapeutics
$1.01
+2.1%
12/21/2022Initiated byChardan CapitalAnalyst M. BarcusBuy$7.00LowView details for Chardan Capital rating of Xilio Therapeutics (NASDAQ:XLO) on 12/21/2022
CleanSpark, Inc. stock logo
CLSK
CleanSpark
$17.45
-3.8%
12/15/2022Target Lowered byChardan Capital-Buy$6.00 -> $5.00LowView details for Chardan Capital rating of CleanSpark (NASDAQ:CLSK) on 12/15/2022
Passage Bio, Inc. stock logo
PASG
Passage Bio
$0.83
-4.6%
12/15/2022Target Lowered byChardan Capital-Buy$18.00 -> $11.00LowView details for Chardan Capital rating of Passage Bio (NASDAQ:PASG) on 12/15/2022
Moderna, Inc. stock logo
MRNA
Moderna
$121.25
-1.0%
12/14/2022Downgraded byChardan CapitalAnalyst Y. LivshitsBuy -> Neutral$186.00 -> $191.00LowView details for Chardan Capital rating of Moderna (NASDAQ:MRNA) on 12/14/2022
Gain Therapeutics, Inc. stock logo
GANX
Gain Therapeutics
$1.12
-3.4%
12/9/2022Initiated byChardan Capital-Buy$4.00LowView details for Chardan Capital rating of Gain Therapeutics (NASDAQ:GANX) on 12/9/2022
Achilles Therapeutics plc stock logo
ACHL
Achilles Therapeutics
$0.83
+1.2%
12/6/2022Target Lowered byChardan Capital-Buy$20.00 -> $17.00LowView details for Chardan Capital rating of Achilles Therapeutics (NASDAQ:ACHL) on 12/6/2022
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
$8.69
+4.3%
11/18/2022Target Lowered byChardan Capital-Buy$30.00 -> $29.00LowView details for Chardan Capital rating of Iovance Biotherapeutics (NASDAQ:IOVA) on 11/18/2022
Dragonfly Energy Holdings Corp. stock logo
DFLI
Dragonfly Energy
$0.88
+6.0%
11/18/2022Initiated byChardan Capital-Buy$15.00LowView details for Chardan Capital rating of Dragonfly Energy (NASDAQ:DFLI) on 11/18/2022
Editas Medicine, Inc. stock logo
EDIT
Editas Medicine
$5.61
+7.7%
11/17/2022Target Lowered byChardan Capital-Buy$43.00 -> $35.00LowView details for Chardan Capital rating of Editas Medicine (NASDAQ:EDIT) on 11/17/2022
Silence Therapeutics plc stock logo
SLN
Silence Therapeutics
$21.74
+1.5%
11/17/2022Target Lowered byChardan Capital-Buy$33.00 -> $29.00LowView details for Chardan Capital rating of Silence Therapeutics (NASDAQ:SLN) on 11/17/2022
Vincerx Pharma, Inc. stock logo
VINC
Vincerx Pharma
$0.65
-0.2%
11/16/2022Target Lowered byChardan Capital-Buy$4.00 -> $3.00LowView details for Chardan Capital rating of Vincerx Pharma (NASDAQ:VINC) on 11/16/2022
PDS Biotechnology Co. stock logo
PDSB
PDS Biotechnology
$4.23
+8.5%
11/14/2022Target Raised byChardan Capital-Buy$15.00 -> $16.00LowView details for Chardan Capital rating of PDS Biotechnology (NASDAQ:PDSB) on 11/14/2022
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
$26.46
+4.5%
11/14/2022Target Raised byChardan CapitalAnalyst Geulah LivshitsBuy$121.00 -> $129.00LowView details for Chardan Capital rating of Intellia Therapeutics (NASDAQ:NTLA) on 11/14/2022
Cabaletta Bio, Inc. stock logo
CABA
Cabaletta Bio
$7.09
-1.4%
11/11/2022Target Lowered byChardan Capital-Buy$13.00 -> $12.00LowView details for Chardan Capital rating of Cabaletta Bio (NASDAQ:CABA) on 11/11/2022

MarketBeat Community Rating for Chardan Capital

Community Ranking:  2.7 out of 5 (
2.7 of 5 stars)
Outperform Votes:  26,641 (Vote Outperform)
Underperform Votes:  23,347 (Vote Underperform)
Total Votes:  49,988
MarketBeat's community ratings are surveys of what our community members think about Chardan Capital and other research firms. Vote "Outperform" if you believe Chardan Capital's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Chardan Capital's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.